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Retinoblastoma with spinal cord compression
Central nervous system (CNS) involvement is not rare in extraocular retinoblastoma, and it is not surprising
to find it in view of its route of spread. However, although spinal recurrence presenting as spinal cord
compression (SCC) is a form of CNS involvement, it is extremely rare. This report describes two patients with
unilateral retinoblastoma with spinal recurrence presenting as SCC. The first patient developed erythematous
swelling of the right foot and weakness of the bilateral lower limbs at 7 months after left enucleation.
Examination revealed pitting edema of bilateral feet and muscle power of 2+ to 3+, with intact sensory function.
The second patient developed weakness of the bilateral lower limbs, and defecative and urinary difficulty for
2 days at 8 months after left enucleation. Examination revealed pitting edema of bilateral feet and muscle
power of 2+, with defective sensory function. Both patients received surgery and local irradiation after SCC.
The first patient refused chemotherapy and survived only 4 months due to disease progression. The second
patient received systemic and intrathecal chemotherapy, and survived 19.5 months without disease progression.
Spinal recurrence with SCC should be suspected when leg weakness or bowel or bladder disturbance occurs
in patients with retinoblastoma. [J Formos Med Assoc 2006;105(6):497–502]
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Retinoblastoma is the most common intraocu-
lar malignancy in childhood. In developed coun-
tries where most patients present with intraocular
disease, the overall survival is reported to be around
90%.1,2 However, extraocular disease is associated
with very poor prognosis and the optimal treat-
ment remains unclear.3 It has been suggested that
central nervous system (CNS) involvement is as-
sociated with the poorest outcome.4 Occasional
reports suggest better outcome after high-dose
chemotherapy and hematopoietic stem cell trans-
plantation.3,5,6 In view of its route of spread, from
the optic nerve to the CNS, it is not surprising to
find CNS involvement in advanced retinoblasto-
ma. However, spinal recurrence presenting as
spinal cord compression (SCC) is extremely rare.
Our review of the literature found only five cases
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reported between 1966 and 2004.7,8 From 1982
to 2004, retinoblastoma was diagnosed in 54
patients at Taipei Veterans General Hospital. CNS
metastasis was found in seven of these patients,
two of whom had spinal recurrence with SCC,
with negative brain computed tomography (CT)
scan. Here, we present these two cases of retino-
blastoma with SCC. As patients with retinoblasto-
ma can expect prolonged survival due to advances
in treatment, it is important to recognize this form
of delayed spread as early as possible.
Case Reports
Case 1
A 6-month-old female infant presented with leu-
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or soft tissue. The tumor was removed completely.
Metastatic retinoblastoma was confirmed. Local
radiotherapy of 2760 cGy was also applied to the
thoracic spine (T-spine) lesion, but her family re-
fused systemic chemotherapy except for low-dose
oral cyclophosphamide. Weakness of bilateral low-
er limbs persisted.
One and a half months later, lung metastasis
over the right lower lung was noted with tumor
fever. Her family continued to refuse chemothera-
py. Dyspnea, cough and fever developed 2 months
later. Radiography showed homogeneous opa-
city over two-thirds of the right lung. Chest CT
showed tumor in the lung with bony destruction.
Her white cell count was 40,300/μL, hemoglobin
was 8.0 g/dL, platelet count was 254 K/μL, lactic
dehydrogenase (LDH) was 4060 μ/L, uric acid (UA)
was 4.7 mg/dL, and inorganic phosphate (iP) was
7.1 mg/dL. The family asked for against-advice
discharge and the patient died soon afterwards, 4
months after the diagnosis of SCC.
Case 2
A 2-year-old girl presented with leukocoria in the
left eye for 1 week. Ocular sonography revealed
an intraocular tumor 12.4 × 13.8 × 10.5 mm in
size, leading to the diagnosis of retinoblastoma.
No family history was found. Her grandmother
objected to enucleation and the patient was lost
to follow-up for 9.3 months. Left enucleation was
kocoria in the left eye for 4 months. Ocular sono-
graphy revealed an intraocular tumor 15 × 15 × 10
mm in size, leading to the diagnosis of retino-
blastoma. No family history was found. Left
enucleation was performed 1 month later. Patho-
logy showed a tumor composed of sheets of small
neoplastic cells with hyperchromatic nuclei. Ro-
settes were occasionally found. The tumor had ex-
tensive necrosis and calcification and was limited
to eyeball tissue. The optic nerve was not involved.
Stage I disease was impressed. Local recurrence
was suspected 1.5 months later due to prosthesis
bulging with eyelid swelling, and was confirmed
by orbital CT. Local radiotherapy with 5300 cGy
was administered, but her family refused chemo-
therapy. Bone scan was negative.
However, 5 months after radiotherapy, ery-
thematous swelling of the right foot and weak-
ness of the bilateral lower limbs occurred. Exami-
nation revealed pitting edema of both feet. Muscle
power of both legs was about 2+ to 3+, with intact
sensory function. Brain CT was negative. Magnetic
resonance imaging (MRI) of the spine revealed
epidural tumor involving the left lateral and pos-
terior part of the spinal cord from T8 to T11 (Figure
1). Bone scan showed positive findings only over
the T11 level of the spine. Laminotomy was per-
formed, and the tumor was found to have com-
pressed the spinal cord and pushed the dural sac
to the right side without invasion to bone, dura
Figure 1. Spinal magnetic resonance imaging shows a left paraspinal soft tissue mass (white arrows) from T6 to T10, with intraspinal extension causing
enlargement of the neuroforamina and right-side deviation of the spinal cord: (A) axial view; (B) transverse view.
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performed at the age of 2 years and 9 months. Path-
ology showed poorly differentiated retinoblast-
oma composed of dense and small oval tumor
cells bearing hyperchromatic nuclei and scanty
cytoplasm, with marked necrosis. The tumor in-
volved vitreous, subretina, choroid and sclera.
Ectropion uvea was noted. The optic nerve was
also involved and the cut end was not free of tu-
mor. Stage IIb disease was impressed. She received
4000 cGy local radiotherapy, but did not receive
chemotherapy.
Eight months after radiotherapy, weakness
of bilateral lower limbs developed with defeca-
tive and urinary difficulty for 2 days. Examination
revealed pitting edema of bilateral feet. Muscle
power of bilateral legs was 2+, with defective sen-
sory function. Brain and orbital CT were negative.
Spine MRI showed bone metastasis from T5 to T7,
and bony destruction with soft tissue mass over
the left vertebral body (Figure 2). Laboratory data
showed LDH of 318 μ/L, UA of 3.5 mg/dL, and iP
of 6.4 mg/dL. Laminotomy over T6 to T9 (5 cm)
revealed extension of the tumor from the neurofo-
ramen to the paraspinal space behind the pleura
and behind the lamina. The intraspinal epidural
tumor, 4 × 2.5 × 0.8 cm in size, was removed piece
by piece. The left T8 spinal nerve was sacrificed
due to tumor encasement. Laminoplasty was
done. Bone scan was negative. Local radiotherapy
of 3600 cGy at the thoracic spine and chemother-
apy with five cycles of vincristine, epirubicin and
cyclophosphamide were given. Six cycles of intra-
thecal chemotherapy with methotrexate was also
given. Bladder and bowel disturbance improved,
but weakness of bilateral lower legs persisted.
The disease was stable for 19.5 months after SCC
diagnosis. She died while sleeping at home due to
an unknown cause.
Discussion
SCC is extremely rare in retinoblastoma. Jubran
et al reported that of 207 patients with retinoblas-
toma treated between 1991 and 1999, only 10 had
extraocular disease at diagnosis or at recurrence;
however, none of these 10 patients had SCC, al-
though seven had meningeal involvement.3 Kao
et al studied 96 children with retinoblastoma
treated between 1978 and 2000, and found that
27 had CNS involvement but none had SCC.9 Pratt
et al reported extraocular disease in 11 of 114 pa-
tients with retinoblastoma treated between 1962
and 1984; among them, only four had a positive
cerebral spinal fluid finding, and none developed
SCC.10 Although de la Monte et al reported that
seven of eight patients with brain metastasis had
spinal recurrence on autopsy, none had SCC.11
Klein et al reported that spinal epidural recurrence
with SCC was found in 112 of 2259 children with
malignant solid tumor treated between 1962 and
1987.12 The most common malignancies present-
  A B
Figure 2. Spinal magnetic resonance imaging shows a bony destruction lesion with an inhomogeneous soft tissue mass over the left
vertebral bodies, T5–T7 (white arrows); there is also a 3.0 × 1.5 cm mass lesion over the posterior mediastinum, just over the left
paravertebral region (black arrows), extending to the pedicle of the thoracic spine: (A) axial view; (B) transverse view.
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ing with SCC were sarcoma, neuroblastoma and
germ cell tumor. However, none of the 112 pa-
tients had retinoblastoma.12 Similarly, Lewis et
al reported that spinal cord disease was found in
24 of 643 children with systemic cancer, but none
of these 24 patients had retinoblastoma.13 These
data illustrate that SCC is extremely rare in retino-
blastoma, either at diagnosis or at recurrence.
Our review of the literature on retinoblastoma
with SCC from 1966 through May 2004 revealed
only five reported cases.7,8 Although data for one
patient was very limited,7 the characteristics of
the remaining four cases and the two cases from
this report are summarized in the Table. The six
patients included two boys and four girls. All six
patients had unilateral involvement: one was right-
sided and five were left-sided. None had a family
history. The mean age at diagnosis was 2 years
and 4.8 months old (range, 6 months – 4 years).
SCC developed a mean of 7.2 months (range, 4–
12 months) after enucleation. The involved level
of the spine included thoracic (6 patients, the most
common), lumbar (3) and sacral spine (3). All
six patients had metastatic tumor extending over
more than one vertebral level. Four patients had
intradural tumors and both of our patients had epi-
dural tumors. Only two patients had brain involve-
ment. The most common symptoms were bilater-
al leg weakness (3 patients), paraplegia (2), uri-
nary or defecative disturbance (2), sensory deficit
(2) and quadriplegia (1). Our two patients survi-
ved 4 and 19.5 months, respectively, and data on
survival for the previously reported patients were
not available.
SCC is an oncologic emergency because it may
cause long-term neurologic dysfunction. Long-
standing cord compression can present as progres-
sive weakness, sensory abnormality and paresis.
Paraplegia and quadriplegia can occur rapidly and
may be irreversible.14,15 Early diagnosis and timely
management can avoid irreversible neurologic
sequelae. Even in severely affected children, sig-
nificant functional recovery may occur.7 In patients
with retinoblastoma, brain metastasis should be
considered whenever neurologic symptoms and
signs occur. However, pediatricians and ophthal-
mologists should also include spinal recurrence
with SCC in the differential diagnosis of patients
with retinoblastoma and neurologic symptoms and
signs.
Treatment-related myelopathies can produce
acute spinal cord dysfunction that may be clinical-
ly indistinguishable from metastatic SCC. Imaging
studies can help in the differential diagnosis. Mye-
lography is an accurate method of diagnosis and
localization. Plain spine films and bone scan are
alternative methods, but their sensitivity rate is only
30–54%.13 Spinal MRI is another very useful tool
for detecting intraspinal tumor.
The treatment of retinoblastoma with SCC in-
cludes neurosurgical decompression, medical treat-
ment with dexamethasone to control inflamma-
tion, local irradiation over the spinal lesion, and
systemic and intrathecal chemotherapy. Previous
studies suggest that when decompressive lamin-
ectomy is undertaken, it should be followed by a
course of radiotherapy.16,17 However decompres-
sive laminectomy in a child may lead to later prob-
lems with scoliosis and kyphosis. Klein et al
recommended decompression in children with
small-cell tumor who have very rapid neurologic
deterioration or complete loss of motor function.
All other patients with small-cell tumor should be
treated medically, with the addition of radiation
in selected cases.12 However, related studies did
not include retinoblastoma patients in their anal-
ysis. Establishing the prognosis and optimal treat-
ment strategy for retinoblastoma with SCC will re-
quire further case studies. No form of intrathecal
therapy, including methotrexate, cytarabine and
hydrocortisone, has been carefully evaluated in
enough retinoblastoma patients with CNS involve-
ment to determine its value when given singly or
in combination.8 Among the intrathecal drugs,
cytarabine and methotrexate are relatively inactive
against retinoblastoma cell lines. However, topo-
tecan and thiotepa, both of which have possible
activity against retinoblastoma, have been used
successfully intrathecally and may have a role in
the treatment of patients with retinoblastoma.17
Our patients had only limited or no improve-
ment in neurological symptoms despite de-
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compression and local radiotherapy. Baten and
Vannucci reported that while tumor type, rate of
progression and degree of paralysis do not affect
outcome, functional recovery was influenced by
the level of spinal lesion.7 Recovery was more of-
ten observed in patients with lesions of the conus
medullaris and the cauda equina.
In conclusion, these two cases of relapsed re-
tinoblastoma with SCC illustrate that when leg
weakness or bowel or bladder disturbance occurs
in a patient with retinoblastoma, spinal recurrence
with SCC should be considered in the differential
diagnosis.
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